nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—Tripelennamine—Rosiglitazone—type 2 diabetes mellitus	0.272	1	CrCrCtD
Disopyramide—CYP3A4—type 2 diabetes mellitus	0.159	1	CbGaD
Disopyramide—ORM1—Nateglinide—type 2 diabetes mellitus	0.088	0.294	CbGbCtD
Disopyramide—SLC22A2—Metformin—type 2 diabetes mellitus	0.0298	0.0994	CbGbCtD
Disopyramide—SLC22A1—Metformin—type 2 diabetes mellitus	0.0259	0.0864	CbGbCtD
Disopyramide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0238	0.0793	CbGbCtD
Disopyramide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0212	0.0707	CbGbCtD
Disopyramide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0194	0.0647	CbGbCtD
Disopyramide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0169	0.0565	CbGbCtD
Disopyramide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0153	0.0511	CbGbCtD
Disopyramide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0116	0.0387	CbGbCtD
Disopyramide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0111	0.0371	CbGbCtD
Disopyramide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0111	0.0371	CbGbCtD
Disopyramide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0105	0.0351	CbGbCtD
Disopyramide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00784	0.0262	CbGbCtD
Disopyramide—CYP3A4—Losartan—type 2 diabetes mellitus	0.00717	0.0239	CbGbCtD
Disopyramide—KCND3—islet of Langerhans—type 2 diabetes mellitus	0.00101	0.0958	CbGeAlD
Disopyramide—KCND2—cardiovascular system—type 2 diabetes mellitus	0.000835	0.0795	CbGeAlD
Disopyramide—KCND2—adipose tissue—type 2 diabetes mellitus	0.000736	0.0701	CbGeAlD
Disopyramide—KCND3—cardiovascular system—type 2 diabetes mellitus	0.000728	0.0693	CbGeAlD
Disopyramide—KCND3—pancreas—type 2 diabetes mellitus	0.000708	0.0674	CbGeAlD
Disopyramide—KCND3—cortex of kidney—type 2 diabetes mellitus	0.000694	0.066	CbGeAlD
Disopyramide—KCND3—adipose tissue—type 2 diabetes mellitus	0.000642	0.0611	CbGeAlD
Disopyramide—SLC22A2—nephron tubule—type 2 diabetes mellitus	0.000576	0.0548	CbGeAlD
Disopyramide—SLC22A2—kidney—type 2 diabetes mellitus	0.000506	0.0482	CbGeAlD
Disopyramide—SLC22A2—cortex of kidney—type 2 diabetes mellitus	0.000493	0.0469	CbGeAlD
Disopyramide—KCND3—liver—type 2 diabetes mellitus	0.00045	0.0429	CbGeAlD
Disopyramide—SCN5A—cardiovascular system—type 2 diabetes mellitus	0.000437	0.0416	CbGeAlD
Disopyramide—CHRM2—cardiovascular system—type 2 diabetes mellitus	0.000372	0.0354	CbGeAlD
Disopyramide—SLC22A1—kidney—type 2 diabetes mellitus	0.000358	0.034	CbGeAlD
Disopyramide—CHRM1—cardiovascular system—type 2 diabetes mellitus	0.000339	0.0322	CbGeAlD
Disopyramide—SLC22A1—adipose tissue—type 2 diabetes mellitus	0.000322	0.0307	CbGeAlD
Disopyramide—CHRM3—kidney—type 2 diabetes mellitus	0.000297	0.0282	CbGeAlD
Disopyramide—Fesoterodine—CYP3A4—type 2 diabetes mellitus	0.000282	0.376	CrCbGaD
Disopyramide—CHRM3—adipose tissue—type 2 diabetes mellitus	0.000267	0.0254	CbGeAlD
Disopyramide—ORM1—liver—type 2 diabetes mellitus	0.000247	0.0235	CbGeAlD
Disopyramide—SLC22A1—liver—type 2 diabetes mellitus	0.000226	0.0215	CbGeAlD
Disopyramide—CYP3A4—kidney—type 2 diabetes mellitus	0.000163	0.0155	CbGeAlD
Disopyramide—Oedema—Valsartan—type 2 diabetes mellitus	0.000152	0.000882	CcSEcCtD
Disopyramide—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000152	0.000881	CcSEcCtD
Disopyramide—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000152	0.000881	CcSEcCtD
Disopyramide—Rash—Glipizide—type 2 diabetes mellitus	0.000151	0.000876	CcSEcCtD
Disopyramide—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000151	0.000876	CcSEcCtD
Disopyramide—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000151	0.000876	CcSEcCtD
Disopyramide—Oedema—Orlistat—type 2 diabetes mellitus	0.00015	0.000872	CcSEcCtD
Disopyramide—Headache—Glipizide—type 2 diabetes mellitus	0.00015	0.000871	CcSEcCtD
Disopyramide—Insomnia—Gliclazide—type 2 diabetes mellitus	0.00015	0.000869	CcSEcCtD
Disopyramide—Shock—Valsartan—type 2 diabetes mellitus	0.000149	0.000868	CcSEcCtD
Disopyramide—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000149	0.000865	CcSEcCtD
Disopyramide—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000149	0.000864	CcSEcCtD
Disopyramide—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000149	0.000862	CcSEcCtD
Disopyramide—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000148	0.000862	CcSEcCtD
Disopyramide—Flatulence—Losartan—type 2 diabetes mellitus	0.000148	0.000862	CcSEcCtD
Disopyramide—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000148	0.000861	CcSEcCtD
Disopyramide—Tension—Losartan—type 2 diabetes mellitus	0.000148	0.000858	CcSEcCtD
Disopyramide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000148	0.000858	CcSEcCtD
Disopyramide—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000148	0.000857	CcSEcCtD
Disopyramide—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000147	0.000856	CcSEcCtD
Disopyramide—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000147	0.000856	CcSEcCtD
Disopyramide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000147	0.000855	CcSEcCtD
Disopyramide—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000147	0.000854	CcSEcCtD
Disopyramide—Urticaria—Glyburide—type 2 diabetes mellitus	0.000146	0.00085	CcSEcCtD
Disopyramide—Nervousness—Losartan—type 2 diabetes mellitus	0.000146	0.000849	CcSEcCtD
Disopyramide—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000146	0.000849	CcSEcCtD
Disopyramide—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000146	0.000847	CcSEcCtD
Disopyramide—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000146	0.000845	CcSEcCtD
Disopyramide—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000145	0.000843	CcSEcCtD
Disopyramide—Anorexia—Valsartan—type 2 diabetes mellitus	0.000145	0.000841	CcSEcCtD
Disopyramide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000145	0.00084	CcSEcCtD
Disopyramide—Chest pain—Metformin—type 2 diabetes mellitus	0.000144	0.000838	CcSEcCtD
Disopyramide—Malaise—Irbesartan—type 2 diabetes mellitus	0.000144	0.000838	CcSEcCtD
Disopyramide—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000144	0.000835	CcSEcCtD
Disopyramide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000144	0.000834	CcSEcCtD
Disopyramide—Syncope—Irbesartan—type 2 diabetes mellitus	0.000143	0.000833	CcSEcCtD
Disopyramide—Discomfort—Metformin—type 2 diabetes mellitus	0.000143	0.000828	CcSEcCtD
Disopyramide—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000143	0.000828	CcSEcCtD
Disopyramide—Nausea—Glipizide—type 2 diabetes mellitus	0.000142	0.000826	CcSEcCtD
Disopyramide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000142	0.000825	CcSEcCtD
Disopyramide—Hypotension—Valsartan—type 2 diabetes mellitus	0.000142	0.000825	CcSEcCtD
Disopyramide—Vision blurred—Losartan—type 2 diabetes mellitus	0.000142	0.000824	CcSEcCtD
Disopyramide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000142	0.000822	CcSEcCtD
Disopyramide—Pain—Gliclazide—type 2 diabetes mellitus	0.000141	0.000821	CcSEcCtD
Disopyramide—Constipation—Gliclazide—type 2 diabetes mellitus	0.000141	0.000821	CcSEcCtD
Disopyramide—Rash—Glimepiride—type 2 diabetes mellitus	0.000141	0.000818	CcSEcCtD
Disopyramide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000141	0.000817	CcSEcCtD
Disopyramide—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000141	0.000817	CcSEcCtD
Disopyramide—Rash—Sitagliptin—type 2 diabetes mellitus	0.00014	0.000815	CcSEcCtD
Disopyramide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00014	0.000814	CcSEcCtD
Disopyramide—Headache—Glimepiride—type 2 diabetes mellitus	0.00014	0.000813	CcSEcCtD
Disopyramide—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.00014	0.000811	CcSEcCtD
Disopyramide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000139	0.00081	CcSEcCtD
Disopyramide—Oedema—Metformin—type 2 diabetes mellitus	0.000138	0.000804	CcSEcCtD
Disopyramide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000138	0.000801	CcSEcCtD
Disopyramide—Angioedema—Losartan—type 2 diabetes mellitus	0.000138	0.000799	CcSEcCtD
Disopyramide—Insomnia—Valsartan—type 2 diabetes mellitus	0.000137	0.000798	CcSEcCtD
Disopyramide—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000136	0.000792	CcSEcCtD
Disopyramide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000136	0.000792	CcSEcCtD
Disopyramide—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000136	0.000791	CcSEcCtD
Disopyramide—Shock—Metformin—type 2 diabetes mellitus	0.000136	0.000791	CcSEcCtD
Disopyramide—Insomnia—Orlistat—type 2 diabetes mellitus	0.000136	0.000789	CcSEcCtD
Disopyramide—Malaise—Losartan—type 2 diabetes mellitus	0.000136	0.000789	CcSEcCtD
Disopyramide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000135	0.000787	CcSEcCtD
Disopyramide—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000135	0.000787	CcSEcCtD
Disopyramide—Vertigo—Losartan—type 2 diabetes mellitus	0.000135	0.000786	CcSEcCtD
Disopyramide—Somnolence—Valsartan—type 2 diabetes mellitus	0.000135	0.000785	CcSEcCtD
Disopyramide—Syncope—Losartan—type 2 diabetes mellitus	0.000135	0.000784	CcSEcCtD
Disopyramide—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000135	0.000783	CcSEcCtD
Disopyramide—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000135	0.000782	CcSEcCtD
Disopyramide—Skin disorder—Metformin—type 2 diabetes mellitus	0.000134	0.000781	CcSEcCtD
Disopyramide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000134	0.000777	CcSEcCtD
Disopyramide—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000134	0.000777	CcSEcCtD
Disopyramide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000133	0.000774	CcSEcCtD
Disopyramide—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000133	0.000774	CcSEcCtD
Disopyramide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000133	0.00077	CcSEcCtD
Disopyramide—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000133	0.00077	CcSEcCtD
Disopyramide—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000132	0.000769	CcSEcCtD
Disopyramide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000132	0.000768	CcSEcCtD
Disopyramide—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000132	0.000768	CcSEcCtD
Disopyramide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000132	0.000767	CcSEcCtD
Disopyramide—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000132	0.000767	CcSEcCtD
Disopyramide—Anorexia—Metformin—type 2 diabetes mellitus	0.000132	0.000766	CcSEcCtD
Disopyramide—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000131	0.000763	CcSEcCtD
Disopyramide—Fatigue—Valsartan—type 2 diabetes mellitus	0.000131	0.000761	CcSEcCtD
Disopyramide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000131	0.000759	CcSEcCtD
Disopyramide—Oedema—Irbesartan—type 2 diabetes mellitus	0.000131	0.000758	CcSEcCtD
Disopyramide—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000131	0.000758	CcSEcCtD
Disopyramide—Pruritus—Glyburide—type 2 diabetes mellitus	0.00013	0.000757	CcSEcCtD
Disopyramide—Constipation—Valsartan—type 2 diabetes mellitus	0.00013	0.000755	CcSEcCtD
Disopyramide—Fatigue—Orlistat—type 2 diabetes mellitus	0.000129	0.000752	CcSEcCtD
Disopyramide—Hypotension—Metformin—type 2 diabetes mellitus	0.000129	0.000751	CcSEcCtD
Disopyramide—Shock—Irbesartan—type 2 diabetes mellitus	0.000128	0.000746	CcSEcCtD
Disopyramide—Pain—Orlistat—type 2 diabetes mellitus	0.000128	0.000746	CcSEcCtD
Disopyramide—Chest pain—Losartan—type 2 diabetes mellitus	0.000128	0.000745	CcSEcCtD
Disopyramide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000128	0.000744	CcSEcCtD
Disopyramide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000128	0.000743	CcSEcCtD
Disopyramide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000127	0.000738	CcSEcCtD
Disopyramide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000127	0.000737	CcSEcCtD
Disopyramide—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000127	0.000737	CcSEcCtD
Disopyramide—Tension—Ramipril—type 2 diabetes mellitus	0.000127	0.000736	CcSEcCtD
Disopyramide—Discomfort—Losartan—type 2 diabetes mellitus	0.000127	0.000736	CcSEcCtD
Disopyramide—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000126	0.000734	CcSEcCtD
Disopyramide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000126	0.000733	CcSEcCtD
Disopyramide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000126	0.000733	CcSEcCtD
Disopyramide—Tolterodine—CYP3A4—type 2 diabetes mellitus	0.000126	0.168	CrCbGaD
Disopyramide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000126	0.000732	CcSEcCtD
Disopyramide—Nervousness—Ramipril—type 2 diabetes mellitus	0.000125	0.000728	CcSEcCtD
Disopyramide—Dry mouth—Losartan—type 2 diabetes mellitus	0.000125	0.000728	CcSEcCtD
Disopyramide—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000124	0.000723	CcSEcCtD
Disopyramide—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000124	0.000722	CcSEcCtD
Disopyramide—Confusional state—Losartan—type 2 diabetes mellitus	0.000124	0.00072	CcSEcCtD
Disopyramide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000124	0.000719	CcSEcCtD
Disopyramide—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000123	0.000716	CcSEcCtD
Disopyramide—Somnolence—Metformin—type 2 diabetes mellitus	0.000123	0.000714	CcSEcCtD
Disopyramide—Oedema—Losartan—type 2 diabetes mellitus	0.000123	0.000714	CcSEcCtD
Disopyramide—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000122	0.000709	CcSEcCtD
Disopyramide—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000122	0.000707	CcSEcCtD
Disopyramide—Shock—Losartan—type 2 diabetes mellitus	0.000121	0.000702	CcSEcCtD
Disopyramide—Urticaria—Valsartan—type 2 diabetes mellitus	0.000121	0.000701	CcSEcCtD
Disopyramide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.00012	0.000699	CcSEcCtD
Disopyramide—Decreased appetite—Metformin—type 2 diabetes mellitus	0.00012	0.000699	CcSEcCtD
Disopyramide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.00012	0.000696	CcSEcCtD
Disopyramide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00012	0.000695	CcSEcCtD
Disopyramide—Fatigue—Metformin—type 2 diabetes mellitus	0.000119	0.000693	CcSEcCtD
Disopyramide—Urticaria—Orlistat—type 2 diabetes mellitus	0.000119	0.000693	CcSEcCtD
Disopyramide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000119	0.00069	CcSEcCtD
Disopyramide—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000119	0.000689	CcSEcCtD
Disopyramide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000119	0.000689	CcSEcCtD
Disopyramide—Constipation—Metformin—type 2 diabetes mellitus	0.000118	0.000687	CcSEcCtD
Disopyramide—Angioedema—Ramipril—type 2 diabetes mellitus	0.000118	0.000685	CcSEcCtD
Disopyramide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000117	0.000681	CcSEcCtD
Disopyramide—Anorexia—Losartan—type 2 diabetes mellitus	0.000117	0.00068	CcSEcCtD
Disopyramide—Vomiting—Glyburide—type 2 diabetes mellitus	0.000117	0.00068	CcSEcCtD
Disopyramide—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000117	0.00068	CcSEcCtD
Disopyramide—Malaise—Ramipril—type 2 diabetes mellitus	0.000116	0.000676	CcSEcCtD
Disopyramide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000116	0.000676	CcSEcCtD
Disopyramide—Rash—Glyburide—type 2 diabetes mellitus	0.000116	0.000674	CcSEcCtD
Disopyramide—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000116	0.000674	CcSEcCtD
Disopyramide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000116	0.000674	CcSEcCtD
Disopyramide—Vertigo—Ramipril—type 2 diabetes mellitus	0.000116	0.000674	CcSEcCtD
Disopyramide—Syncope—Ramipril—type 2 diabetes mellitus	0.000116	0.000672	CcSEcCtD
Disopyramide—Headache—Glyburide—type 2 diabetes mellitus	0.000115	0.00067	CcSEcCtD
Disopyramide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000115	0.000668	CcSEcCtD
Disopyramide—Hypotension—Losartan—type 2 diabetes mellitus	0.000115	0.000667	CcSEcCtD
Disopyramide—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000114	0.000662	CcSEcCtD
Disopyramide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000114	0.000659	CcSEcCtD
Disopyramide—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000113	0.000659	CcSEcCtD
Disopyramide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000113	0.000657	CcSEcCtD
Disopyramide—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000113	0.000654	CcSEcCtD
Disopyramide—Constipation—Irbesartan—type 2 diabetes mellitus	0.000112	0.000649	CcSEcCtD
Disopyramide—Pain—Irbesartan—type 2 diabetes mellitus	0.000112	0.000649	CcSEcCtD
Disopyramide—Insomnia—Losartan—type 2 diabetes mellitus	0.000111	0.000646	CcSEcCtD
Disopyramide—Paraesthesia—Losartan—type 2 diabetes mellitus	0.00011	0.000641	CcSEcCtD
Disopyramide—Urticaria—Metformin—type 2 diabetes mellitus	0.00011	0.000638	CcSEcCtD
Disopyramide—Chest pain—Ramipril—type 2 diabetes mellitus	0.00011	0.000638	CcSEcCtD
Disopyramide—Dyspnoea—Losartan—type 2 diabetes mellitus	0.00011	0.000636	CcSEcCtD
Disopyramide—Nausea—Glyburide—type 2 diabetes mellitus	0.000109	0.000635	CcSEcCtD
Disopyramide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000109	0.000635	CcSEcCtD
Disopyramide—Somnolence—Losartan—type 2 diabetes mellitus	0.000109	0.000634	CcSEcCtD
Disopyramide—Asthenia—Valsartan—type 2 diabetes mellitus	0.000109	0.000633	CcSEcCtD
Disopyramide—Discomfort—Ramipril—type 2 diabetes mellitus	0.000109	0.000631	CcSEcCtD
Disopyramide—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000108	0.000628	CcSEcCtD
Disopyramide—Asthenia—Orlistat—type 2 diabetes mellitus	0.000108	0.000626	CcSEcCtD
Disopyramide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000108	0.000625	CcSEcCtD
Disopyramide—Pruritus—Valsartan—type 2 diabetes mellitus	0.000108	0.000624	CcSEcCtD
Disopyramide—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000108	0.000624	CcSEcCtD
Disopyramide—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000107	0.00062	CcSEcCtD
Disopyramide—Confusional state—Ramipril—type 2 diabetes mellitus	0.000106	0.000617	CcSEcCtD
Disopyramide—Pruritus—Orlistat—type 2 diabetes mellitus	0.000106	0.000617	CcSEcCtD
Disopyramide—Fatigue—Losartan—type 2 diabetes mellitus	0.000106	0.000615	CcSEcCtD
Disopyramide—Oedema—Ramipril—type 2 diabetes mellitus	0.000105	0.000612	CcSEcCtD
Disopyramide—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000105	0.000611	CcSEcCtD
Disopyramide—Pain—Losartan—type 2 diabetes mellitus	0.000105	0.00061	CcSEcCtD
Disopyramide—Constipation—Losartan—type 2 diabetes mellitus	0.000105	0.00061	CcSEcCtD
Disopyramide—Rash—Gliclazide—type 2 diabetes mellitus	0.000104	0.000606	CcSEcCtD
Disopyramide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000104	0.000605	CcSEcCtD
Disopyramide—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000104	0.000604	CcSEcCtD
Disopyramide—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000104	0.000602	CcSEcCtD
Disopyramide—Shock—Ramipril—type 2 diabetes mellitus	0.000104	0.000602	CcSEcCtD
Disopyramide—Headache—Gliclazide—type 2 diabetes mellitus	0.000104	0.000602	CcSEcCtD
Disopyramide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000103	0.0006	CcSEcCtD
Disopyramide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000103	0.000599	CcSEcCtD
Disopyramide—CYP3A4—liver—type 2 diabetes mellitus	0.000103	0.0098	CbGeAlD
Disopyramide—Levomethadyl Acetate—CYP3A4—type 2 diabetes mellitus	0.000103	0.137	CrCbGaD
Disopyramide—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000103	0.000597	CcSEcCtD
Disopyramide—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000102	0.000594	CcSEcCtD
Disopyramide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000102	0.000592	CcSEcCtD
Disopyramide—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000101	0.000588	CcSEcCtD
Disopyramide—Dizziness—Valsartan—type 2 diabetes mellitus	0.0001	0.000584	CcSEcCtD
Disopyramide—Anorexia—Ramipril—type 2 diabetes mellitus	0.0001	0.000583	CcSEcCtD
Disopyramide—Dizziness—Orlistat—type 2 diabetes mellitus	9.93e-05	0.000577	CcSEcCtD
Disopyramide—Asthenia—Metformin—type 2 diabetes mellitus	9.93e-05	0.000577	CcSEcCtD
Disopyramide—Hypotension—Ramipril—type 2 diabetes mellitus	9.85e-05	0.000572	CcSEcCtD
Disopyramide—Nausea—Gliclazide—type 2 diabetes mellitus	9.82e-05	0.000571	CcSEcCtD
Disopyramide—Pruritus—Metformin—type 2 diabetes mellitus	9.79e-05	0.000569	CcSEcCtD
Disopyramide—Urticaria—Losartan—type 2 diabetes mellitus	9.76e-05	0.000567	CcSEcCtD
Disopyramide—Body temperature increased—Losartan—type 2 diabetes mellitus	9.72e-05	0.000564	CcSEcCtD
Disopyramide—Vomiting—Valsartan—type 2 diabetes mellitus	9.66e-05	0.000561	CcSEcCtD
Disopyramide—Rash—Valsartan—type 2 diabetes mellitus	9.58e-05	0.000556	CcSEcCtD
Disopyramide—Dermatitis—Valsartan—type 2 diabetes mellitus	9.57e-05	0.000556	CcSEcCtD
Disopyramide—Vomiting—Orlistat—type 2 diabetes mellitus	9.55e-05	0.000554	CcSEcCtD
Disopyramide—Insomnia—Ramipril—type 2 diabetes mellitus	9.53e-05	0.000554	CcSEcCtD
Disopyramide—Headache—Valsartan—type 2 diabetes mellitus	9.52e-05	0.000553	CcSEcCtD
Disopyramide—Diarrhoea—Metformin—type 2 diabetes mellitus	9.47e-05	0.00055	CcSEcCtD
Disopyramide—Rash—Orlistat—type 2 diabetes mellitus	9.47e-05	0.00055	CcSEcCtD
Disopyramide—Paraesthesia—Ramipril—type 2 diabetes mellitus	9.46e-05	0.00055	CcSEcCtD
Disopyramide—Dermatitis—Orlistat—type 2 diabetes mellitus	9.46e-05	0.000549	CcSEcCtD
Disopyramide—Headache—Orlistat—type 2 diabetes mellitus	9.41e-05	0.000546	CcSEcCtD
Disopyramide—Dyspnoea—Ramipril—type 2 diabetes mellitus	9.39e-05	0.000546	CcSEcCtD
Disopyramide—Asthenia—Irbesartan—type 2 diabetes mellitus	9.37e-05	0.000544	CcSEcCtD
Disopyramide—Somnolence—Ramipril—type 2 diabetes mellitus	9.37e-05	0.000544	CcSEcCtD
Disopyramide—Dyspepsia—Ramipril—type 2 diabetes mellitus	9.28e-05	0.000539	CcSEcCtD
Disopyramide—Pruritus—Irbesartan—type 2 diabetes mellitus	9.24e-05	0.000537	CcSEcCtD
Disopyramide—Decreased appetite—Ramipril—type 2 diabetes mellitus	9.16e-05	0.000532	CcSEcCtD
Disopyramide—Dizziness—Metformin—type 2 diabetes mellitus	9.15e-05	0.000531	CcSEcCtD
Disopyramide—Methadone—CYP1A2—type 2 diabetes mellitus	9.11e-05	0.121	CrCbGaD
Disopyramide—Fatigue—Ramipril—type 2 diabetes mellitus	9.09e-05	0.000528	CcSEcCtD
Disopyramide—Nausea—Valsartan—type 2 diabetes mellitus	9.03e-05	0.000524	CcSEcCtD
Disopyramide—Constipation—Ramipril—type 2 diabetes mellitus	9.01e-05	0.000523	CcSEcCtD
Disopyramide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.93e-05	0.000519	CcSEcCtD
Disopyramide—Nausea—Orlistat—type 2 diabetes mellitus	8.92e-05	0.000518	CcSEcCtD
Disopyramide—Dextropropoxyphene—CYP3A4—type 2 diabetes mellitus	8.89e-05	0.118	CrCbGaD
Disopyramide—Asthenia—Losartan—type 2 diabetes mellitus	8.82e-05	0.000512	CcSEcCtD
Disopyramide—Vomiting—Metformin—type 2 diabetes mellitus	8.8e-05	0.000511	CcSEcCtD
Disopyramide—Rash—Metformin—type 2 diabetes mellitus	8.72e-05	0.000507	CcSEcCtD
Disopyramide—Dermatitis—Metformin—type 2 diabetes mellitus	8.72e-05	0.000506	CcSEcCtD
Disopyramide—Pruritus—Losartan—type 2 diabetes mellitus	8.69e-05	0.000505	CcSEcCtD
Disopyramide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	8.68e-05	0.000504	CcSEcCtD
Disopyramide—Headache—Metformin—type 2 diabetes mellitus	8.67e-05	0.000503	CcSEcCtD
Disopyramide—Dizziness—Irbesartan—type 2 diabetes mellitus	8.64e-05	0.000502	CcSEcCtD
Disopyramide—Diarrhoea—Losartan—type 2 diabetes mellitus	8.41e-05	0.000488	CcSEcCtD
Disopyramide—Urticaria—Ramipril—type 2 diabetes mellitus	8.37e-05	0.000486	CcSEcCtD
Disopyramide—Body temperature increased—Ramipril—type 2 diabetes mellitus	8.33e-05	0.000484	CcSEcCtD
Disopyramide—Vomiting—Irbesartan—type 2 diabetes mellitus	8.3e-05	0.000482	CcSEcCtD
Disopyramide—Rash—Irbesartan—type 2 diabetes mellitus	8.23e-05	0.000478	CcSEcCtD
Disopyramide—Dermatitis—Irbesartan—type 2 diabetes mellitus	8.23e-05	0.000478	CcSEcCtD
Disopyramide—Nausea—Metformin—type 2 diabetes mellitus	8.22e-05	0.000477	CcSEcCtD
Disopyramide—Headache—Irbesartan—type 2 diabetes mellitus	8.18e-05	0.000475	CcSEcCtD
Disopyramide—Dizziness—Losartan—type 2 diabetes mellitus	8.13e-05	0.000472	CcSEcCtD
Disopyramide—Vomiting—Losartan—type 2 diabetes mellitus	7.81e-05	0.000454	CcSEcCtD
Disopyramide—Nausea—Irbesartan—type 2 diabetes mellitus	7.76e-05	0.00045	CcSEcCtD
Disopyramide—Rash—Losartan—type 2 diabetes mellitus	7.75e-05	0.00045	CcSEcCtD
Disopyramide—Dermatitis—Losartan—type 2 diabetes mellitus	7.74e-05	0.00045	CcSEcCtD
Disopyramide—Headache—Losartan—type 2 diabetes mellitus	7.7e-05	0.000447	CcSEcCtD
Disopyramide—Asthenia—Ramipril—type 2 diabetes mellitus	7.56e-05	0.000439	CcSEcCtD
Disopyramide—Pruritus—Ramipril—type 2 diabetes mellitus	7.46e-05	0.000433	CcSEcCtD
Disopyramide—Nausea—Losartan—type 2 diabetes mellitus	7.3e-05	0.000424	CcSEcCtD
Disopyramide—Diarrhoea—Ramipril—type 2 diabetes mellitus	7.21e-05	0.000419	CcSEcCtD
Disopyramide—Dizziness—Ramipril—type 2 diabetes mellitus	6.97e-05	0.000405	CcSEcCtD
Disopyramide—Vomiting—Ramipril—type 2 diabetes mellitus	6.7e-05	0.000389	CcSEcCtD
Disopyramide—Rash—Ramipril—type 2 diabetes mellitus	6.64e-05	0.000386	CcSEcCtD
Disopyramide—Dermatitis—Ramipril—type 2 diabetes mellitus	6.64e-05	0.000386	CcSEcCtD
Disopyramide—Headache—Ramipril—type 2 diabetes mellitus	6.6e-05	0.000383	CcSEcCtD
Disopyramide—Nausea—Ramipril—type 2 diabetes mellitus	6.26e-05	0.000364	CcSEcCtD
Disopyramide—Methadone—CYP3A4—type 2 diabetes mellitus	6.03e-05	0.0802	CrCbGaD
Disopyramide—SLC22A2—Metabolism—PPARA—type 2 diabetes mellitus	6.74e-06	7.83e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	6.7e-06	7.79e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	6.7e-06	7.79e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GSTM1—type 2 diabetes mellitus	6.69e-06	7.78e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.67e-06	7.75e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	6.57e-06	7.64e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—LPL—type 2 diabetes mellitus	6.56e-06	7.63e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CCL2—type 2 diabetes mellitus	6.55e-06	7.61e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—AGT—type 2 diabetes mellitus	6.52e-06	7.58e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	6.48e-06	7.54e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	6.45e-06	7.5e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.45e-06	7.5e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.45e-06	7.5e-05	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	6.45e-06	7.5e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—AKT2—type 2 diabetes mellitus	6.43e-06	7.48e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ADCY5—type 2 diabetes mellitus	6.43e-06	7.47e-05	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	6.43e-06	7.47e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CALM1—type 2 diabetes mellitus	6.41e-06	7.46e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GPX1—type 2 diabetes mellitus	6.4e-06	7.45e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—MTHFR—type 2 diabetes mellitus	6.4e-06	7.44e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—APOE—type 2 diabetes mellitus	6.39e-06	7.43e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	6.37e-06	7.41e-05	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	6.36e-06	7.4e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.33e-06	7.36e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—APOA1—type 2 diabetes mellitus	6.32e-06	7.35e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PPARA—type 2 diabetes mellitus	6.28e-06	7.3e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CD36—type 2 diabetes mellitus	6.24e-06	7.25e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.23e-06	7.24e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.23e-06	7.24e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.23e-06	7.24e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PPP2CA—type 2 diabetes mellitus	6.16e-06	7.16e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.11e-06	7.1e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.09e-06	7.08e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—AGT—type 2 diabetes mellitus	6.08e-06	7.07e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.05e-06	7.03e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.03e-06	7.01e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.03e-06	7.01e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CALM1—type 2 diabetes mellitus	5.98e-06	6.95e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	5.97e-06	6.94e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	5.97e-06	6.94e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	5.97e-06	6.94e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—APOE—type 2 diabetes mellitus	5.96e-06	6.93e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AVP—type 2 diabetes mellitus	5.95e-06	6.92e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	5.95e-06	6.92e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	5.94e-06	6.91e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	5.92e-06	6.89e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	5.91e-06	6.88e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	5.91e-06	6.87e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	5.9e-06	6.86e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	5.89e-06	6.85e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	5.89e-06	6.85e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—APOA1—type 2 diabetes mellitus	5.89e-06	6.85e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	5.86e-06	6.82e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	5.85e-06	6.81e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.85e-06	6.81e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	5.84e-06	6.79e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	5.84e-06	6.79e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	5.8e-06	6.74e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	5.78e-06	6.72e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	5.77e-06	6.71e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	5.75e-06	6.68e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.74e-06	6.68e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.73e-06	6.66e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	5.69e-06	6.62e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.68e-06	6.6e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.67e-06	6.59e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.66e-06	6.58e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	5.62e-06	6.53e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.6e-06	6.51e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PPARG—type 2 diabetes mellitus	5.57e-06	6.47e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	5.52e-06	6.42e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	5.51e-06	6.4e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	5.5e-06	6.4e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	5.49e-06	6.38e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.48e-06	6.37e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—INS—type 2 diabetes mellitus	5.46e-06	6.35e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	5.44e-06	6.33e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	5.44e-06	6.32e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.39e-06	6.27e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.37e-06	6.25e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.32e-06	6.19e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.29e-06	6.16e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.29e-06	6.16e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.29e-06	6.16e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.29e-06	6.16e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PPARG—type 2 diabetes mellitus	5.19e-06	6.03e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.17e-06	6.01e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.15e-06	5.99e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.1e-06	5.93e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—INS—type 2 diabetes mellitus	5.09e-06	5.92e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.08e-06	5.9e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.07e-06	5.9e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.06e-06	5.88e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.01e-06	5.82e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ALB—type 2 diabetes mellitus	5.01e-06	5.82e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	4.96e-06	5.77e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	4.94e-06	5.75e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	4.89e-06	5.69e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	4.79e-06	5.57e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3R1—type 2 diabetes mellitus	4.79e-06	5.57e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—NOS3—type 2 diabetes mellitus	4.79e-06	5.57e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.73e-06	5.5e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.72e-06	5.49e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.72e-06	5.48e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.71e-06	5.48e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	4.71e-06	5.48e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.7e-06	5.47e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—INS—type 2 diabetes mellitus	4.7e-06	5.47e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	4.7e-06	5.46e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.67e-06	5.43e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	4.67e-06	5.42e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.66e-06	5.41e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	4.65e-06	5.41e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.63e-06	5.39e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.62e-06	5.37e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	4.62e-06	5.37e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	4.62e-06	5.37e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	4.6e-06	5.35e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	4.6e-06	5.35e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.57e-06	5.32e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.56e-06	5.31e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	4.56e-06	5.3e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	4.56e-06	5.3e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.55e-06	5.29e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.5e-06	5.24e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	4.46e-06	5.19e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.46e-06	5.19e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.4e-06	5.12e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	4.38e-06	5.09e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.35e-06	5.06e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.34e-06	5.05e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.32e-06	5.02e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.32e-06	5.02e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	4.31e-06	5.01e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.3e-06	5e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.23e-06	4.92e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.21e-06	4.89e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.21e-06	4.89e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.21e-06	4.89e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.18e-06	4.86e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	4.12e-06	4.79e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	4.12e-06	4.79e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.12e-06	4.79e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.1e-06	4.77e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.1e-06	4.77e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	4.08e-06	4.75e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.06e-06	4.73e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.06e-06	4.72e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	3.94e-06	4.59e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	3.93e-06	4.57e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	3.89e-06	4.53e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.88e-06	4.51e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.87e-06	4.5e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.83e-06	4.45e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.81e-06	4.44e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.81e-06	4.43e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.8e-06	4.42e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.8e-06	4.42e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.8e-06	4.41e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.78e-06	4.4e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.77e-06	4.39e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.77e-06	4.39e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.77e-06	4.39e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	3.77e-06	4.38e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.77e-06	4.38e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.76e-06	4.37e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.75e-06	4.36e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.7e-06	4.31e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.67e-06	4.27e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.62e-06	4.21e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.61e-06	4.2e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.59e-06	4.18e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.58e-06	4.16e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.46e-06	4.02e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.46e-06	4.02e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.45e-06	4.01e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.45e-06	4.01e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.45e-06	4.01e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.41e-06	3.97e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.41e-06	3.97e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.41e-06	3.97e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.41e-06	3.97e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.27e-06	3.8e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.27e-06	3.8e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.26e-06	3.78e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	3.24e-06	3.77e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	3.21e-06	3.74e-05	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.96e-06	3.45e-05	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.95e-06	3.43e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.94e-06	3.41e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.93e-06	3.4e-05	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.93e-06	3.4e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.92e-06	3.39e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.91e-06	3.38e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.9e-06	3.37e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.88e-06	3.35e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.82e-06	3.28e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.82e-06	3.28e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.81e-06	3.26e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.77e-06	3.23e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.77e-06	3.22e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.77e-06	3.22e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.75e-06	3.19e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.74e-06	3.18e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.74e-06	3.18e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.71e-06	3.15e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.69e-06	3.13e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.69e-06	3.13e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.68e-06	3.12e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.66e-06	3.09e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.61e-06	3.04e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.57e-06	2.98e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.56e-06	2.97e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	2.55e-06	2.96e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.53e-06	2.94e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.51e-06	2.92e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.5e-06	2.91e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.49e-06	2.9e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.48e-06	2.89e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.46e-06	2.86e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.44e-06	2.84e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.41e-06	2.8e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.31e-06	2.69e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.29e-06	2.66e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.28e-06	2.65e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.27e-06	2.64e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.26e-06	2.62e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.24e-06	2.61e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.23e-06	2.6e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.21e-06	2.57e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	2.2e-06	2.56e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.2e-06	2.55e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.16e-06	2.51e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.15e-06	2.5e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.13e-06	2.47e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	2.05e-06	2.39e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	1.9e-06	2.2e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.87e-06	2.18e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.84e-06	2.14e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.72e-06	2e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.72e-06	2e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.7e-06	1.98e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.68e-06	1.96e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.61e-06	1.87e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.61e-06	1.87e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.59e-06	1.85e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.58e-06	1.84e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.57e-06	1.82e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.47e-06	1.71e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.41e-07	8.61e-06	CbGpPWpGaD
